Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in …
Y Qin, H Zhang, L Feng, H Wei, Y Wu, C Jiang… - Annals of …, 2022 - Taylor & Francis
Background Myelodysplastic syndromes (MDS) encompass a group of heterogeneous
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in …
Y Qin, H Zhang, L Feng, H Wei, Y Wu… - Annals of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Myelodysplastic syndromes (MDS) encompass a group of heterogeneous
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
[HTML][HTML] Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in …
Y Qin, H Zhang, L Feng, H Wei, Y Wu, C Jiang… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Myelodysplastic syndromes (MDS) encompass a group of heterogeneous
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in …
Y Qin, H Zhang, L Feng, H Wei, Y Wu, C Jiang… - Annals of …, 2022 - europepmc.org
Background Myelodysplastic syndromes (MDS) encompass a group of heterogeneous
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …
haematopoietic stem cell malignancies characterised by ineffective haematopoiesis …